SAM
FPRX

Sectoral Asset Management’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Sectoral Asset Management’s Portfolio FPRX Stock Details FPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-13,920
Closed -$194K – 153
2018
Q3 		$194K Buy
+13,920
New +$207K 0.02% 139
2014
Q2 		– Sell
-32,372
Closed -$636K – 72
2014
Q1 		$636K Buy
+32,372
New +$550K 0.03% 60

Other funds holding FPRX

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Sectoral Asset Management's FPRX Position: Q4 2018 in Review

Sectoral Asset Management sold out of Five Prime Therapeutics, Inc. (FPRX) in Q4 2018, closing a stake of 13,920 shares — an estimated $194K sold.

Sectoral Asset Management first reported a position in FPRX in Q1 2014 and held it in 2 quarters. The position peaked at $636K in Q1 2014. 116 funds tracked by Wall St. Rank hold FPRX as of Q4 2018.

  • Sectoral Asset Management reported no remaining Five Prime Therapeutics, Inc. position as of Q4 2018 after selling out during the quarter.
  • Sectoral Asset Management sold 13,920 Five Prime Therapeutics, Inc. shares in Q4 2018, an estimated $194K.
  • Sectoral Asset Management first reported a position in Five Prime Therapeutics, Inc. in Q1 2014 and held it in 2 quarters.
  • Sectoral Asset Management's Five Prime Therapeutics, Inc. position peaked at $636K in Q1 2014.
  • 116 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q4 2018.

Based on Sectoral Asset Management's 13F filing for Q4 2018, filed 12 Feb 2019.